1
Enquiry period
with 24.02.2023 15:30
to 01.03.2023 10:00
2
Bidding period
with 01.03.2023 10:00
to 06.03.2023 10:00
3
Auction
with 07.03.2023 14:00
to 07.03.2023 14:09
4
Evaluation

5
Contract

Status Evaluation
Estimated value without VAT 283 617,05 MDL
Period of clarifications: 24 Feb 2023, 15:30 - 1 Mar 2023, 10:00
Submission of proposals: 1 Mar 2023, 10:00 - 6 Mar 2023, 10:00

Supplier technical support:

(+373) 79999801

“Achiziţionarea medicamentelor pentru Boala Addison în scopul realizării Programului Național ”Combatarea maladiilor rare” pentru anul 2023, repetat 5”

Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
24 Feb 2023, 14:42
Date modified
24 Feb 2023, 15:30
Achizitii.md ID
21074581
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Funding sources
List of lots
Documents of the procurement procedure
Propunerea tehnică
Technical Specifications
Propunerea tehnică
24.02.23 15:30
DUAE Model
Bidding Documents
DUAE Model
24.02.23 15:30
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
24.02.23 15:30
Anunt de participare din 24.02.2023.signed
Bidding Documents
Anunt de participare din 24.02.2023.signed
24.02.23 15:30
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
24.02.23 15:30
Contract model_PN cu COP
Bidding Documents
Contract model_PN cu COP
24.02.23 15:30
Documentatia standard.signed
Bidding Documents
Documentatia standard.signed
24.02.23 15:30
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
24.02.23 15:30
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
24.02.23 15:30
Propunerea financiară
Technical Specifications
Propunerea financiară
24.02.23 15:30
Only authorized platform users may ask questions during the clarification period.